Last Updated: August 3, 2026

SODIUM CHLORIDE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Sodium Chloride patents expire, and what generic alternatives are available?

Sodium Chloride is a drug marketed by Abbott, B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Hospira, Miles, Otsuka Icu Medcl, Medefil Inc, Hikma, Nexus, Spectra Mdcl Devices, Fresenius Medcl, Gvs Tm, Laboratorios Grifols, Liebel-flarsheim, Icu Medical Inc, Jubilant Cadista, Nephron, Taro, and Abraxis Pharm. and is included in fifty-four NDAs.

The generic ingredient in SODIUM CHLORIDE is potassium chloride; sodium chloride. There are two hundred and forty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the potassium chloride; sodium chloride profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for SODIUM CHLORIDE?
What are the global sales for SODIUM CHLORIDE?
What is Average Wholesale Price for SODIUM CHLORIDE?

Summary for SODIUM CHLORIDE

US Patents:	0
Applicants:	20
NDAs:	54

US Patents and Regulatory Information for SODIUM CHLORIDE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Taro	SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	sodium chloride	SOLUTION;INJECTION	077407-002	Aug 11, 2006	AP	RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Liebel-flarsheim	SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	sodium chloride	INJECTABLE;INJECTION	021569-001	Jul 27, 2006		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
B Braun	SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	potassium chloride; sodium chloride	INJECTABLE;INJECTION	018722-004	Nov 9, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Fresenius Kabi Usa	SODIUM CHLORIDE 23.4%	sodium chloride	INJECTABLE;INJECTION	217796-001	Jul 11, 2023	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Baxter Hlthcare	SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	sodium chloride	SOLUTION;INJECTION	020178-001	Dec 7, 1992	AP	RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Hospira	SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	sodium chloride	SOLUTION;INJECTION	019465-002	Jul 15, 1985	AP	RX	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Baxter Hlthcare	SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	sodium chloride	SOLUTION;INJECTION	016677-004	Oct 30, 1985		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.